HomeNewsBusinessEconomyEconomic impact of second wave will not be as severe as the first: Finance Secretary

Economic impact of second wave will not be as severe as the first: Finance Secretary

The pace of vaccination holds the key to the momentum and sustainability of the economic recovery.

June 10, 2021 / 18:38 IST
Story continues below Advertisement
According to ICRA, after the satiation of the pent-up demand seen during the festive season in 2020, purchases of consumer durables may be restricted, which would impact capacity utilisation in FY2022.
According to ICRA, after the satiation of the pent-up demand seen during the festive season in 2020, purchases of consumer durables may be restricted, which would impact capacity utilisation in FY2022.

The government does not expect the economic impact of the second wave of the COVID-19 pandemic to be as severe as the first, said finance secretary TV Somanathan in an interaction with the media.

That is pretty much the consensus view among economists, multilateral institutions such as the International Monetary Fund and the World Bank, and the Reserve Bank of India.

Story continues below Advertisement

Although the central bank has toned down its optimism on economic growth from earlier in the year, it still projects India’s gross domestic product (GDP) to grow at 9.5 percent in FY22. In its assessment of the economy published in the middle of May, although it has warned of a potential demand shock, it also said its assessment was that “loss of momentum is not as severe as at this time a year ago.”

To be sure, it is not as if there is no impact from the second wave. Earlier, the RBI had projected growth at 10.5 percent. Private sector economists too have pared projections to 9-10 percent now from 11-14 percent earlier. The spread of infections in the hinterland and the potential reluctance of households to spend even after the second wave subsides could further dampen the recovery.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show